PHP
HCAT icon

Parkman Healthcare Partners’s Health Catalyst HCAT Stock Holding History

Parkman Healthcare Partners’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-63,104
Closed -$914K – 93
2022
Q2 		$914K Sell
63,104
-16,642
-21% -$284K 0.34% 60
2022
Q1 		$2.08M Buy
79,746
+27,068
+51% +$768K 0.61% 46
2021
Q4 		$2.09M Buy
52,678
+2,163
+4% +$98.6K 0.46% 56
2021
Q3 		$2.53M Hold
50,515
– – 0.64% 48
2021
Q2 		$2.8M Sell
50,515
-14,759
-23% -$786K 0.61% 49
2021
Q1 		$3.05M Sell
65,274
-9,726
-13% -$471K 0.71% 45
2020
Q4 		$3.27M Buy
+75,000
New +$2.77M 0.84% 48

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Parkman Healthcare Partners's HCAT Position: Q3 2022 in Review

Parkman Healthcare Partners sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 63,104 shares — an estimated $914K sold.

Parkman Healthcare Partners first reported a position in HCAT in Q4 2020 and held it in 7 quarters. The position peaked at $3.27M in Q4 2020. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • Parkman Healthcare Partners reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
  • Parkman Healthcare Partners sold 63,104 Health Catalyst shares in Q3 2022, an estimated $914K.
  • Parkman Healthcare Partners first reported a position in Health Catalyst in Q4 2020 and held it in 7 quarters.
  • Parkman Healthcare Partners's Health Catalyst position peaked at $3.27M in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Parkman Healthcare Partners's 13F filing for Q3 2022, filed 14 Nov 2022.